.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Medtronic
UBS
AstraZeneca
Argus Health
Farmers Insurance
Accenture
Citi
Baxter

Generated: July 24, 2017

DrugPatentWatch Database Preview

MICROZIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Microzide, and what generic Microzide alternatives are available?

Microzide is a drug marketed by Allergan Sales Llc and is included in one NDA.

The generic ingredient in MICROZIDE is hydrochlorothiazide. There are thirty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.

Summary for Tradename: MICROZIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list12
Bulk Api Vendors: see list77
Clinical Trials: see list3
Patent Applications: see list7,469
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MICROZIDE at DailyMed

Pharmacology for Tradename: MICROZIDE

Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc
MICROZIDE
hydrochlorothiazide
CAPSULE;ORAL020504-001Dec 27, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Chinese Patent Office
Citi
Covington
Cipla
AstraZeneca
Teva
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot